News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
An infographic on this significant milestone.
August 11, 2021Interim Review 2021
A summary of highlights from the year so far.
August 11, 2021White Paper 2021
Our White Paper looks at the state of mental health care in the US, with a focus on treatment-resistant depression.
July 29, 2021Guy Goodwin joins COMPASS Pathways as Chief Medical Officer
July 21, 2021Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training
July 05, 2021COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
June 30, 2021COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
June 28, 2021COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression
June 23, 2021COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
June 11, 2021COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
June 03, 2021COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
May 13, 2021COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
April 30, 2021COMPASS Pathways announces pricing of public offering
April 27, 2021COMPASS Pathways launches proposed public offering
April 15, 2021New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
April 12, 2021COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference
April 01, 2021COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
March 23, 2021COMPASS Pathways granted two US patents
March 09, 2021Our annual review, with a letter to our shareholders and some highlights from our year
March 09, 2021COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020
March 01, 2021COMPASS Pathways plc to participate in Cowen’s 41st Annual Health Care Conference
February 09, 2021COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
February 03, 2021COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
January 28, 2021COMPASS Pathways plc to participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health Conference
January 08, 2021COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
January 06, 2021COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences
December 16, 2020COMPASS Pathways News | December 2020 Issue
Our highlights in the second half of 2020 as we work towards building a world of mental wellbeing for everyone.
November 12, 2020COMPASS Pathways plc announces financial results for third quarter 2020
November 09, 2020COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
November 05, 2020COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020
November 04, 2020COMPASS Pathways plc to participate in Berenberg and Evercore investor conferences
October 26, 2020COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO
September 22, 2020COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares